We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The National Institute of Allergy and Infectious Diseases, part of the NIH, has selected two of U.S. drugmaker Biothera's drug candidates for a new program designed to identify and facilitate the development of radiation and nuclear medical countermeasures.
Sanofi pasteur, the vaccines arm of French drugmaker sanofi-aventis, has within the framework of a collaborative research project funded by the European Commission, FLUPAN, generated the first clinical trial lot of a new generation of H7N1 pandemic vaccine.
More than 7 million Afghan children under 5 will be vaccinated against the poliovirus this week during a joint campaign launched by Afghanistan's health ministry and the United Nations Children's Fund.
Bioenvision Inc., will be formally launching Evoltra throughout Europe at the 38th Congress of the International Society of Pediatric Oncology (SIOP) in Geneva, Switzerland from September 17-21.
Intercell AG announced that it has closed a worldwide nonexclusive agreement under which Wyeth has the right to use Intercell's fully synthetic novel adjuvant IC31TM in various selected infectious disease vaccine programs.
Swiss drugmaker Novartis said on Saturday that clinical tests had shown its once-yearly Aclasta medicine had proved effective in reducing incidence of bone fracture in women with postmenopausal osteoporosis (PMO).
Serono and Syntonix Pharmaceuticals Inc. announced that they have entered into an agreement under which the companies will evaluate Syntonix' FSH:Fc SynFusion products for further development.
Cell Therapeutics Inc., a maker of treatments for cancer, said Monday it entered into a licensing agreement worth up to $285 million with drug maker Novartis AG for a cancer drug in clinical trials.
Zimbabwean antiretroviral (ARV) drug manufacturers are seeking certification from the World Health Organization (WHO) to receive funding from the UN to produce more affordable HIV drugs, according to media reports.